Drug price drops: Here are the first 10 subject to new Medicare reforms

The White House announced today the first 10 drugs subject to new Medicare price negotiations, after a law was passed allowing the government to lean on drug companies for a better deal. The move could save taxpayers billions of dollars in the first year alone. And it’s supported by a vast majority of Americans, at a time when many are struggling to meet the mounting cost of some lifesaving prescription drugs. The drugs on the list are among the most costly to the Medicare Part D program — Eliquis, for...